Baxter's Stock Struggles to Push Through $50

Filed under: Baxter Intl (BAX), Stocks to Buy

I first discussed Baxter International (BAX) here on March 13, 2009, at a price of $51.16, and share have since drifted below $50 after clearing that key, psychological resistance level. The calculation is to maintain the trade, but Baxter needs to show some improvement in the months ahead.

Baxter makes a variety of medical products across three divisions: drugs and vaccines, dialysis equipment, and IV supplies. The 2011 performance likely will be led by continued growth in IV therapies, global injectables and anesthesia products, and renal care (including revenue growth in its peritoneal dialysis product).

Continue reading Baxter's Stock Struggles to Push Through $50

Baxter's Stock Struggles to Push Through $50 originally appeared on BloggingStocks on Sun, 30 Jan 2011 11:10:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Full story at http://www.pheedcontent.com/click.phdo?i=fa86cab1c3100eb7deb714d6383ae56e